Get the Stockscreener App
3.95
7.63%
0.28
Trisalus Life Sciences Inc stock is traded at $3.95, with a volume of 103.14K.
It is up +7.63% in the last 24 hours and down -23.60% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$3.67
Open:
$3.72
24h Volume:
103.14K
Relative Volume:
1.27
Market Cap:
$149.46M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.2543
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
-5.50%
1M Performance:
-23.60%
6M Performance:
-29.08%
1Y Performance:
-30.34%
1-Day Range:
$3.60
$3.99
1-Week Range:
$3.46
$4.30
52-Week Range:
$3.46
$6.04
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
3.95 | 150.00M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
Published on: 2025-08-10 22:56:45 - Newser
Has TriSalus Life Sciences Inc. Equity Warrant formed a bullish divergencePortfolio Allocation Strategy for Stability - Newser
Order flow analysis tools used on TriSalus Life Sciences Inc. Equity WarrantFree Long Hold Safe Return Strategy - Newser
Detecting support and resistance levels for TriSalus Life Sciences Inc.Stock Forecast Tools for Retail Traders - Newser
Understanding TriSalus Life Sciences Inc. Equity Warrant’s price movementFree Risk Adjusted Technical Entry Plan - Newser
News impact scoring models applied to TriSalus Life Sciences Inc.ROI Prediction from Long-Term Holding Plans - Newser
Chart based analysis of TriSalus Life Sciences Inc. Equity Warrant trendsMarket Correction Proof Stock Screening Analysis - Newser
Chart based exit strategy for TriSalus Life Sciences Inc. Equity WarrantFree Conservative Long Term Growth Plans - Newser
Applying sector rotation models to TriSalus Life Sciences Inc. Equity WarrantFree High Yield Stocks With Buy Confirmation - Newser
Applying big data sentiment scoring on TriSalus Life Sciences Inc.5-Year Price Trend Summary and Analysis - Newser
Can TriSalus Life Sciences Inc. Rally Enough to Break EvenExpert Verified Stock Trade Ideas Backed by Data - beatles.ru
Is TriSalus Life Sciences Inc. Equity Warrant stock entering bullish territoryStock Portfolio Risk and Return Analysis - Newser
Will TriSalus Life Sciences Inc. price bounce be sustainableCapital Protection Strategy With Risk Analysis - Newser
Is TriSalus Life Sciences Inc. trending in predictive chart modelsBuy and Hold Strategy for Capital Safety - Newser
Applying big data sentiment scoring on TriSalus Life Sciences Inc. Equity WarrantTechnical Reversal Setup with Risk Limits - Newser
TriSalus Life Sciences Inc. Equity Warrant stock trend outlook and recovery pathMomentum Trend Signal Weekly Recap Summary - Newser
Will TriSalus Life Sciences Inc. see short term momentumBuy Strategy Review With Performance Summary - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.Controlled Entry Strategy With Safety Analytics - Newser
Earnings Preview: TLSI to Report Financial Results Post-market on August 12 - 富途牛牛
TriSalus Life Sciences Inc. Equity Warrant stock outlook for YEARAccurate Forecast System with AI Support - Newser
Applying Wyckoff theory to TriSalus Life Sciences Inc. stockDaily Upside Movement Prediction With Data - Newser
TriSalus Bets Big On Growing Its Cancer Device Platform - Finimize
Forecasting TriSalus Life Sciences Inc. Equity Warrant price range with options dataFree AI Screening for Swing Trade Picks - Newser
News impact scoring models applied to TriSalus Life Sciences Inc. Equity WarrantInvestment Timing Strategy with Market Filters - Newser
Can TriSalus Life Sciences Inc. Regain Momentum After BreakdownCapital Preserving Trade Plan Templates Shared - beatles.ru
When is the best time to exit TriSalus Life Sciences Inc. Equity WarrantFree Consistent Income Focused Trade List - Newser
Should I hold or sell TriSalus Life Sciences Inc. stock in 2025Capitalize on emerging market trends - Jammu Links News
What are the latest earnings results for TriSalus Life Sciences Inc. Equity WarrantRapid wealth accumulation - Jammu Links News
How does TriSalus Life Sciences Inc. compare to its industry peersTriple-digit wealth increases - Jammu Links News
What is TriSalus Life Sciences Inc. company’s growth strategyRobust investment performance - Jammu Links News
When is TriSalus Life Sciences Inc. stock expected to show significant growthBuild a diversified portfolio for steady growth - Jammu Links News
What are the technical indicators suggesting about TriSalus Life Sciences Inc. Equity WarrantOutstanding capital returns - Jammu Links News
Why is TriSalus Life Sciences Inc. Equity Warrant stock attracting strong analyst attentionUnlock real-time stock alerts for quick profits - Jammu Links News
What are analysts’ price targets for TriSalus Life Sciences Inc. in the next 12 monthsRapid profit acceleration - Jammu Links News
What is the risk reward ratio of investing in TriSalus Life Sciences Inc. stockDouble-digit growth - Jammu Links News
What is the dividend policy of TriSalus Life Sciences Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
What is TriSalus Life Sciences Inc. Equity Warrant company’s growth strategyFree Capital Allocation Plans - Jammu Links News
Does TriSalus Life Sciences Inc. Equity Warrant fit your quant trading modelTen-Year Sector Performance and Summary Analysis - Newser
TriSalus Life Sciences Inc. Equity Warrant Stock Analysis and ForecastCapitalize on high-yield stock opportunities - Jammu Links News
Can trapped investors hope for a rebound in TriSalus Life Sciences Inc.Free Daily Growth Stock Pick Reports - Newser
How volatile is TriSalus Life Sciences Inc. stock compared to the marketGet timely market insights for better trades - Jammu Links News
What drives TriSalus Life Sciences Inc. stock priceCapitalize on market trends with expert guidance - Jammu Links News
When is TriSalus Life Sciences Inc. Equity Warrant stock expected to show significant growth - Jammu Links News
What analysts say about TriSalus Life Sciences Inc. Equity Warrant stockFree Buy/Sell Signal Notifications - Jammu Links News
Is it the right time to buy TriSalus Life Sciences Inc. stockExplosive market performance - Jammu Links News
TriSalus Life Sciences Inc. Stock Analysis and ForecastFree Investment Risk Control - Jammu Links News
What institutional investors are buying TriSalus Life Sciences Inc. stockConsistently profitable trades - Jammu Links News
Is TriSalus Life Sciences Inc. Equity Warrant a growth stock or a value stockExplosive earnings growth - Jammu Links News
How does TriSalus Life Sciences Inc. Equity Warrant compare to its industry peersBreakthrough profit margins - Jammu Links News
What is the dividend policy of TriSalus Life Sciences Inc. Equity Warrant stockCapitalize on proven investment strategies - Jammu Links News
What catalysts could drive TriSalus Life Sciences Inc. Equity Warrant stock higher in 2025Unrivaled growth potential - Jammu Links News
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):